VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China - PRNewswire

18 Jul 2019 - PRNewswire

usx:vnrx

---

VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China

18 Jul 2019 - Yahoo News
AUSTIN, Texas, July 18, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") has executed a contract under the previously announced Memorandum of Understanding, with Shanghai Fosun Long March Medical Science Co., Ltd. ("Fosun Long March") to help introduce the Nu.Q(TM) platform ...
usx:vnrx

---

VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding - PRNewswire

10 Jul 2019 - PRNewswire

usx:vnrx

---

VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding

10 Jul 2019 - Yahoo News
AUSTIN, Texas, July 10, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded additional non-dilutive funding in the form of a non-repayable cash grant totaling approximately $1.4 million from the Walloon Region, Belgium. To date, Agencies ...
usx:vnrx

---

Thursday 6/13 Insider Buying Report: FFNW, VNRX

13 Jun 2019 - Nasdaq
As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy they expect to make money So let s look at two noteworthy recent insider buys At First Financial Northwest a filing with the SEC revealed that on Wednesday Director Kevin
usx:vnrx

---

Did You Miss VolitionRx's (NYSEMKT:VNRX) Impressive 116% Share Price Gain?

11 Jun 2019 - Yahoo News
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
usx:vnrx

---

SeaChange International shares sink after posting disappointing 1Q earnings, revenue misses - Proactive Investors USA & Canada

6 Jun 2019 - Proactive Investors USA & Canada

usx:vnrx

---

VNRX: 2019 Could Be Busy Year of Data Releases, Assay Validations - Zacks Small Cap Research

22 May 2019 - Zacks Small Cap Research

usx:vnrx

---

VNRX: 2019 Could Be Busy Year of Data Releases, Assay Validations

22 May 2019 - Yahoo News
On May 9th VolitionRx (VNRX) reported financial results for their fiscal 2019 first quarter ending March 31st. The study will include 1,200 participants receiving low-dose CT scan, 1,000 of which have lung cancer.
usx:vnrx

---

VolitionRX Ltd. to Host Earnings Call

9 May 2019 - Yahoo News
NEW YORK, NY / ACCESSWIRE / May 9, 2019 / VolitionRX Ltd. (NYSEMKT: VNRX ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 9, 2019 at 8:30 AM Eastern Time. ...
usx:vnrx

---